Pending EO 12866 Regulatory Review

RIN: 1210-AB37	Received Date: 09/10/2025
Title: Improving Transparency into Pharmacy Benefit Manager Fee Disclosure
Agency/Subagency: DOL / EBSA	Stage: Proposed Rule
Legal Deadline: None	Economically Significant: Yes
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No